Search

Jazz Pharmaceuticals PLC

Cerrado

SectorSanidad

255.93 -0.22

Resumen

Variación precio

24h

Actual

Mínimo

255.75

Máximo

257.63

Métricas clave

By Trading Economics

Ingresos

-100M

193M

Ventas

139M

1.2B

P/B

Media del Sector

2,528.6

68.51

BPA

4.89

Margen de beneficios

15.956

Empleados

2,890

EBITDA

-296M

248M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+10.63% upside

Dividendos

By Acuity

Próximas Ganancias

4 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

2.8B

16B

Apertura anterior

256.15

Cierre anterior

255.93

Noticias sobre sentimiento de mercado

By Acuity

29%

71%

48 / 340 Clasificación en Healthcare

Jazz Pharmaceuticals PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 ago 2026, 19:36 UTC

Jazz Pharmaceuticals shares are higher today, reflecting broader market gains amid expectations the Federal Reserve may pause interest rate hikes.

6 ago 2026, 19:21 UTC

Jazz Pharmaceuticals PLC shares are lower today, despite earlier gains. Mixed economic signals contribute to cautious sentiment ahead of the non-farm payrolls report.

5 ago 2026, 19:36 UTC

News

Shares of Jazz Pharmaceuticals PLC are lower today, despite earlier gains. The company raised its full-year revenue guidance, driven by strong performance from Xywav.

4 ago 2026, 20:04 UTC

Social Media
News

Jazz Pharmaceuticals PLC shares rise as analysts upgrade price targets, following strong Q2 results that beat revenue estimates and boosted 2026 sales guidance.

3 ago 2026, 23:02 UTC

News

Jazz Pharmaceuticals reported Q2 revenues of $1.208 billion, exceeding expectations. Shares advanced in after-market trading following the raised full-year guidance.

31 jul 2026, 23:21 UTC

Jazz Pharmaceuticals PLC shares are lower in after-market trading, pulled back from earlier session highs amid broader market declines, particularly in major tech stocks.

30 jul 2026, 19:59 UTC

Jazz Pharmaceuticals shares are higher, reflecting broader market recovery amid significant gains in the technology sector. The stock is near the upper end of its one-month range.

29 jul 2026, 18:26 UTC

Jazz Pharmaceuticals PLC is trading higher during Wednesday's session, with fluctuations within a routine range and positioned above its 20-day moving average.

28 jul 2026, 23:46 UTC

Jazz Pharmaceuticals PLC shares are higher in after-market trading, recovering from an early low and remaining above the 20-day moving average.

27 jul 2026, 19:37 UTC

Social Media

Jazz Pharmaceuticals PLC is trading higher, recently reaching a new 52-week high amid increased investor interest and significant average volume exceeding $50 million.

24 jul 2026, 20:07 UTC

Jazz Pharmaceuticals PLC shares are lower today amid broader market dynamics influenced by recent oil price volatility, despite remaining above its 20-day moving average.

21 jul 2026, 19:02 UTC

Jazz Pharmaceuticals PLC is trading higher today, despite no specific news. Positive sentiment in the semiconductor sector may be contributing to overall investor optimism.

20 jul 2026, 23:36 UTC

News

Jazz Pharmaceuticals PLC will report second-quarter results on August 3, contributing to positive investor sentiment as shares trade higher after market hours.

Comparación entre iguales

Cambio de precio

Jazz Pharmaceuticals PLC previsión

Precio Objetivo

By TipRanks

10.63% repunte

Estimación a 12 Meses

Media 283.82 USD  10.63%

Máximo 315 USD

Mínimo 229 USD

De acuerdo con 17 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Jazz Pharmaceuticals PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

17 ratings

16

Comprar

1

Mantener

0

Vender

Sentimiento

By Acuity

48 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$